MEG3 and gastric cancer: In addition, we added the 5-Aza + sh-MEG3 treatment group to further demonstrate that the growth of gastric cancer after DNA methylation inhibition was not significantly improved compared with the MEG3 overexpression and 5-Aza treatment groups.